| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |